intensifying existing manufacturing processes, or consuming MIC simultaneously with its production.
3.2 Estimate the projected costs of alternative approaches identified above.
3.3 Evaluate the projected benefits of alternative approaches identified above, including any cost savings, reduced compliance costs, liability reductions, reduced emergency preparedness costs, and reduced likelihood or severity of a worst-case MIC release or other release affecting the surrounding community.
3.4 Compare this analysis to the inherently safer process assessments conducted by Bayer and previous owners of the Institute site.
3.5 Comment, if possible, on whether and how inherently safer process assessments can be utilized during post-accident investigations.